Targeting the ‘Undruggable’ Driver Protein, KRAS, in Epithelial Cancers: Current Perspective
10.3390/cells12040631
Saved in:
Main Authors: | Lam, KK, Wong, SH, Cheah, PY |
---|---|
Other Authors: | MICROBIOLOGY AND IMMUNOLOGY |
Format: | Review |
Published: |
MDPI AG
2024
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/248900 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
KRAS-specific antibody binds to KRAS protein inside colorectal adenocarcinoma cells and inhibits its localization to the plasma membrane
by: Lam, KK, et al.
Published: (2024) -
Engineering SARS-CoV-2 specific cocktail antibodies into a bispecific format improves neutralizing potency and breadth
by: Ku, Zhiqiang, et al.
Published: (2023) -
Cytosolic factors block antibody binding to the C-terminal cytoplasmic tail of the KDEL receptor
by: Tang, B.L., et al.
Published: (2014) -
Recent developments in chemical conjugation strategies targeting native amino acids in proteins and their applications in antibody-drug conjugates
by: Kang, Min Sun, et al.
Published: (2023) -
Block copolymer micelles for nanomedicine
by: Li, W., et al.
Published: (2014)